as 04-18-2025 1:42pm EST
LiveRamp Holdings Inc is a global technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust.
Founded: | 2018 | Country: | United States |
Employees: | N/A | City: | SAN FRANCISCO |
Market Cap: | 2.2B | IPO Year: | 1987 |
Target Price: | $38.17 | AVG Volume (30 days): | 587.3K |
Analyst Decision: | Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.00 | EPS Growth: | N/A |
52 Week Low/High: | $21.45 - $38.00 | Next Earning Date: | 05-21-2025 |
Revenue: | $728,708,000 | Revenue Growth: | 14.50% |
Revenue Growth (this year): | 14.82% | Revenue Growth (next year): | 7.94% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Bloomston Kimberly | RAMP | CHIEF PRODUCT OFFICER | Feb 25 '25 | Sell | $30.88 | 3,611 | $111,507.68 | 86,061 | |
Hussain Mohsin | RAMP | CHIEF TECHNOLOGY OFFICER | Feb 14 '25 | Sell | $33.67 | 3,554 | $119,663.18 | 57,594 | |
Sharma Vihan | RAMP | CHIEF REVENUE OFFICER | Feb 10 '25 | Sell | $35.56 | 39,845 | $1,416,888.20 | 110,902 | |
Bloomston Kimberly | RAMP | CHIEF PRODUCT OFFICER | Feb 6 '25 | Sell | $36.00 | 2,528 | $91,008.00 | 86,061 | |
Bloomston Kimberly | RAMP | CHIEF PRODUCT OFFICER | Jan 27 '25 | Sell | $34.00 | 2,529 | $85,986.00 | 86,061 |
RAMP Breaking Stock News: Dive into RAMP Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
Argus Research
10 days ago
StockStory
16 days ago
Business Wire
16 days ago
Argus Research
17 days ago
Insider Monkey
21 days ago
Argus Research
24 days ago
StockStory
a month ago
The information presented on this page, "RAMP LiveRamp Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.